DNA testing of colorectal polyps improves insight into hereditary risks

For 10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients.
Technology Networks

Not All Cancer Risk Is in the Blood—Sometimes It’s in the Polyp

Researchers show that genetic analysis of colorectal polyps can uncover cancer predisposition missed by blood-based testing.
News-Medical.Net on MSN

DNA analysis of colorectal polyps improves diagnosis and treatment

In about 5–10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients.
pharmaphorum

Amgen, AZ's Tezspire challenges Dupixent in nasal polyps

Amgen and AstraZeneca's Tezspire has claimed FDA approval as a treatment for chronic rhinosinusitis with nasal polyps (CRSwNP), its second indication after severe asthma. The anti-TSLP antibody has ...